Funds and ETFs Johnson & Johnson

Equities

JNJ

US4781601046

Pharmaceuticals

Market Closed - Nyse 04:00:02 2024-03-01 pm EST 5-day change 1st Jan Change
162.1 USD +0.46% Intraday chart for Johnson & Johnson +0.17% +3.43%

ETFs positioned on Johnson & Johnson

Name Weight AuM 1st Jan change Investor Rating
14.01% 232 M€ +6.08% -
12.91% 19 M€ +5.16% -
5.67% 9 M€ -.--% -
4.85% 16 M€ +9.55% -
4.35% 5 M€ -72.95% -
3.66% 115 M€ +10.32% -
3.20% 2 M€ -.--% -
2.57% 20 M€ -.--% -
2.55% 672 M€ -3.11%
2.31% 2,361 M€ +10.80%
1.99% 877 M€ -0.21%
1.90% 2 M€ +14.69% -
1.88% 16 M€ -3.37%
1.86% 47 M€ -3.38% -
1.71% 41 M€ -.--%
1.59% 312 M€ -.--% -
1.58% 197 M€ +7.31% -
1.58% 1 M€ +0.04%
1.58% 471 M€ +4.50%
1.58% 639 M€ +8.94%
1.54% 260 M€ +6.04%
Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - pharmaceutical products (55.4%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, gastro-intestinal illnesses, infectious, immunological, neurological, dermatological diseases, etc.; - medical products and equipment (28.9%): diagnostic systems, orthopedic and gynecological equipment, surgical materials, etc. for use by healthcare professionals; - consumer health products (15.7%): OTC drugs (Tylenol, Sudafed, Benadryl, Zyrtec, Motrin, Nicorette and other brands), health and beauty products (Aveeno, Clean & Clear, Dr. CI:Labo, Neutrogena and OGX), baby care products (Johnson's and Aveeno Baby), oral care products (Listerine), feminine hygiene products (Stayfree and Carefree and o.b.), wound care products (Band-Aid and Neosporin) etc. At the end of 2022, Johnson & Johnson has 89 manufacturing facilities located in the United States (28), North America (9), Europe (27), Africa and Asia/Pacific (25). Net sales are distributed geographically as follows: the United States (51.2%), Europe (24.7%), Asia/Pacific and Africa (17.7%) and other (6.4%).
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
22
Last Close Price
162.1 USD
Average target price
174.2 USD
Spread / Average Target
+7.47%
Consensus
  1. Stock
  2. Equities
  3. Stock Johnson & Johnson - Nyse
  4. Funds and ETFs Johnson & Johnson
-40% Limited-time offer: Our subscriptions help you unlock the best investment opportunities.
SIGN UP NOW